PTC THERAPEUTICS INTERNATIONAL LIMITED

Upstaza is used for the treatment of patients aged 18 months and older presenting with aromatic L-amino acid decarboxylase (AADC) deficiency, a hereditary condition that can affect nervous system development, movement, feeding, breathing, speech, and mental abilities.

Dosage form: solution for infusion

ATC: A16AB26